ASTER.CEPHAC
The SGS.CEPHAC Group is a leading European contract research organization (CRO) providing clinical and bioanalytical services to companies developing pharmaceutical, cosmetic and OTC health care products.
The SGS.Cephac Group is devoted to high quality, value added early drug development: Phase I - II, Proof of Concept, PK/PD and Bioanalysis studies. The group is headquartered in Paris - France and offers its services on an international scale to clients in mainland Europe, Scandinavia, the UK, the US and Japan.
BIOANALYTICAL RESEARCH
SGS.CEPHAC has been involved for over twenty years in the bioanalysis of drugs from biological matrices in support of animal and clinical trials. With a dedicated staff of over 100 trained personnel at our Bioanalytical site in Poitiers, we offer unparalleled service when it comes to meeting your outsourcing needs.
The SGS.CEPHAC Group has one of the largest European centers for bioanalysis which comprises a GLP Grade A laboratory with a large sophisticated and up-to-date equipment park (LC-MS/MS, GC-MS, HPLC, RIA). Our company has developed a high number of proprietary bioanalytical methods that enable us to offer analysis under optimal conditions with regard to quality and timelines. We are likewise competent in method development and transfer. Our PK group can also help you design protocols and interpret data.
Our Group utilises Watson LIMS to streamline its laboratory operations. In addition to automating sample management, the Watson LIMS solution is interfaced with "Aster-Cephac Net", an innovative intranet portal providing real-time access to customer results and reports: customer area
|
